User Fee programs help the Food and Drug Administration (FDA) to ensure timely review and support the development of innovative therapeutics.
Testimony before Energy and Commerce Committee, Subcommittee on Health, on Examining FDA’s Medical Device User Fee Program
Published March 27, 2017
On March 28, Alliance for Aging Research Vice President of Public Policy Cynthia Bens testified before the United States House of Representatives’ Energy and Commerce Committee, Subcommittee on Health, at its hearing on the U.S. Food and Drug Administration’s Medical Device User Fee Program.